13F Holdings
中文EN

EBRCZ EBR Systems, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1347123 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-45.6%
TTM EPS YoY83.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin11.4%
Operating margin-737.5%
Net margin-774.5%
FCF margin-919.0%
EBITDA margin-726.4%

Returns

ROE-112.9%
ROA-51.7%
ROIC (approx.)-57.8%
Asset turnover0.07x

Leverage & solvency

Liabilities / assets47.8%
Debt / equity0.54x
Current ratio2.11x
Interest coverage-11.50x

Cash quality & payout

Operating cash flow / net income1.07x
Accruals ratio3.6%
Payout ratio—
Capex / revenue91.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$1.62M——
Cost of revenue$1.13M——
Gross profit$490,000——
R&D expense$23.94M$27.07M$27.15M
SG&A expense$22.64M$11.25M$7.40M
Operating income-$46.09M-$38.32M-$34.55M
Interest expense$5.64M$6.03M$4.48M
Pretax income-$48.76M-$40.80M-$35.04M
Income tax$2,000$2,000$1,625
Net income-$48.76M-$40.80M-$35.04M
EBITDA-$45.68M-$37.73M-$33.80M
EPS (basic)-0.12-0.13-0.12
EPS (diluted)-0.12-0.13-0.12
Weighted avg. shares (diluted)417.33M325.00M288.88M
Banking
Net interest income—$3.18M$3.28M
Balance sheet
Cash & equivalents$5.79M$6.92M$14.58M
Short-term investments$47.40M$53.75M$57.74M
Inventory$13.79M$1.39M$0
Current assets$73.11M$64.47M$74.37M
PP&E, net$5.48M$795,000$1.09M
Total assets$97.23M$73.56M$78.90M
Current liabilities$14.05M$8.33M$6.45M
Long-term debt$41.80M$41.84M—
Total debt$41.80M$41.84M—
Total liabilities$71.64M$49.20M$47.84M
Shareholders' equity$25.59M$24.36M$31.06M
Net debt$36.01M$34.92M—
Shares outstanding45.03M371.08M307.02M
Cash flow statement
Operating cash flow-$53.19M-$41.23M-$32.70M
Capital expenditure$3.68M$273,000$354,054
Free cash flow-$56.88M-$41.50M-$33.05M
Investing cash flow$7.84M$1.11M-$8.64M
Financing cash flow$46.83M$32.48M$40.47M
Depreciation & amortization$403,000$587,000$752,257
Stock-based compensation$3.05M$1.74M$1.31M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.